Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New Pfizer/BioNTech COVID-19 Vaccine Data Confirm Prior Results, Show T-Cell Boost

21 Jul 2020

• By Mandy Jackson

Vaccination against the new Corona Virus SARS-CoV-2: A syringe being drawn up with SARS-CoV-2 vaccination. — Pfizer and BioNTech report results from a second Phase I/II study, which was conducted in Germany • Source: Shutterstock

Related Content

COVID-19 Vaccine Should Demonstrate At Least 50% Effectiveness, US FDA Says

01 Jul 2020

COVID-19: The Race To Develop A Vaccine

09 Jun 2020

An Ambitious COVID-19 Vaccine Development Plan For Pfizer And BioNtech

28 Apr 2020

Pfizer Unveils Promising Early Data On COVID-19, Sends Moderna Shares Down

01 Jul 2020

Moderna’s COVID-19 Vaccine Spurs Immune Response In All Phase I Subjects At All Doses

15 Jul 2020

UK Is First To Sign Up Pfizer For COVID-19 Vaccine, AstraZeneca For Antibodies

20 Jul 2020

Solid Phase I Results For AstraZeneca COVID-19 Vaccine, But Two Doses Needed To Hit Efficacy Goal

20 Jul 2020

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Additional Topics

Coronavirus COVID-19 Vaccines Clinical Trials Research & Development Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.